← Open Payments lookup

SARAH CAIN: Open Payments

NPI 1952168098 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$447 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $290 · 2025 $447

Food & beverage: $447
CompanyPaymentsAmount
Janssen Biotech, Inc.3$183
Genmab U.S., Inc.2$52
KYOWA KIRIN, INC.2$52
Celgene Corporation2$39
GlaxoSmithKline, LLC.1$30
ARRAY BIOPHARMA INC1$27
Incyte Corporation1$26
Stemline Therapeutics Inc.1$19
AstraZeneca Pharmaceuticals LP1$18

Products named: RYBREVANT, TECVAYLI, Epkinly, POTELIGEO, REBLOZYL, JEMPERLI, BRAFTOVI, MONJUVI.

Industry payments across TX — which companies pay providers there.